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Abstract
Background:  The Advisory Committee on Immunization Practices advocates that influenza
immunization is the most effective method for prevention of illness due to influenza.
Recommendations for vaccination of children against influenza have been revised several times
since 2002, and as of 2008 include all children 6 months to 18 years of age. Nevertheless, influenza
immunization rates have remained low.
Methods: We surveyed practicing pediatricians in Maryland in the spring of 2007 to determine
their attitudes and practices toward childhood influenza immunization.
Results: The overall response to the survey was 21%. A total of 61% of respondents reported that
immunization either is cost neutral or produces a loss, and 36.6% noted it was minimally profitable.
Eighty-six percent of respondents were receptive to supporting school-based immunization
programs, and 61% indicated that they would participate in such programs. Respondents reported
higher rates of immunization of select patient groups than those noted by the Centers for Disease
Control and Prevention
Conclusion:  Vaccination was reported to occur at multiple types of patient encounters, as
recommended. Survey respondents stated that practice-based immunization was not a profitable
service. Pediatricians were supportive of school-based immunization programs, and more than half
stated they would be actively involved in such programs. School-based programs may be critical to
achieving high vaccination coverage in the school-aged population.
Background
Influenza causes annual epidemics and affects all seg-
ments of the population. Children experience the highest
rates of infection, shed the greatest quantities of influenza
virus for extended periods of time, and have long been
recognized as vectors for spread of disease [1-4]. Young
children are also at increased risk of complications from
influenza. Because of high rates of influenza-related hos-
pitalizations in children younger than 24 months of age,
the Advisory Committee on Immunization Practices
(ACIP) encouraged universal vaccination of children aged
6 to 23 months in 2002 [5]. In 2004, the ACIP made a for-
mal recommendation for universal vaccination among
children 6 to 23 months [6]. Later, this recommendation
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was expanded to children 6 to ≤ 59 months of age [7]. Rec-
ommendations by the ACIP for children were subse-
quently further expanded and as of 2008 included the
following groups: all children 6 months to 18 years of age,
children with certain medical conditions, children who
are contacts of persons at higher risk for complications
due to influenza [4]. In addition, ACIP recommends vac-
cination for all persons, including school-aged children,
who want to reduce the risk of becoming ill with influenza
or of transmitting influenza to others [4].
Despite these recommendations, estimates of influenza
vaccination levels reported by the US Centers for Disease
Control and Prevention (CDC) fall below targets pro-
posed in the Healthy People 2010 initiative [4,8,9]. Possi-
ble reasons for low rates of influenza vaccination may be
limited practitioner recognition of the severity of influ-
enza in young children, difficulty in identifying appropri-
ate high-risk candidates, confusion about which provider
is responsible for immunization when multiple providers
are involved in patient care, and underutilization of strat-
egies known to improve vaccination rates [10,11].
This study was designed to determine the attitudes and
practices of pediatricians regarding immunizing children
against influenza.
Methods
The Maryland Chapter of the American Academy of Pedi-
atrics consists of 1100 members, of which 900 maintain a
current practice. The 900 practicing pediatricians in the
state were issued a survey by mail during the spring of
2007 to determine their attitudes and practices regarding
childhood influenza vaccination, based on their own
opinions and personal recollections. Thirteen questions
were selected for inclusion in the questionnaire [see addi-
tional file 1] and were divided into 4 major categories: size
and location of practice (questions 1, 2, 5); influenza
immunization practices regarding patient selection and
specific type of vaccine administered (questions 3, 3a, 4,
12, 13); profitability of immunization (questions 6, 7);
and participation in school-based influenza immuniza-
tion programs (questions 8–11).
Questions were free response, multiple choice, or simple
yes or no; more than 1 answer could be selected for some
multiple-choice questions. Data were tabulated based on
the number of responses for each choice per individual
question divided by the total number of responses for that
question. Free text responses to question 7 were subjec-
tively categorized and the percentage of responses in each
category was calculated. Clinicians were provided with a
return envelope, were sent weekly e-mail reminders to
prompt them to return the survey by a specified cutoff
date, and were compensated $10 for completing the sur-
vey. The survey was coordinated by the Maryland Chapter
of the American Academy of Pediatrics, and all results
were tabulated and analyzed by the sponsor (MedIm-
mune, Gaithersburg, MD).
Results
Response rate
Of the 900 pediatricians who were surveyed, a total of 190
questionnaires were returned and analyzed, for an overall
response rate of 21.1%. Some of those who replied did
not provide responses to all questions. Responses were
balanced by sex and practitioners spanned a 66-year range
in age, with the median age being younger than 50 years
(Table 1).
Size and location of practice
A little more than one third of practices were located in
urban areas, approximately one half were situated in sub-
urbs, 6% were based in rural areas, and <3% were in a
combination of areas. The median practice was 6000
patients, of which fewer than one third, on average, was
eligible for the Vaccines for Children (VFC) program
(Table 1).
Influenza immunization practices
For all age groups and specified at-risk candidates, the per-
centage of patients reportedly immunized by respondents
exceeded national averages reported by the CDC [4]. With
respect to the setting for immunization, nearly all practi-
tioners reported immunizing patients during regular vis-
its, and approximately three quarters also reported
vaccinating during sick visits and at special influenza vac-
cine clinics. Fewer than half of all practices had any form
of callback system to contact at-risk candidates who had
not yet been immunized (Table 1).
Various influenza vaccines are marketed, including inacti-
vated preservative-free formulations in single-dose pre-
filled syringes; inactivated thimerosal-containing
formulations in multidose vials; and a live attenuated,
preservative-free, single-dose nasal spray. Concerning the
specific types of vaccine administered, those who
responded noted that inactivated influenza vaccines were
administered more frequently than the nasal spray. Use of
inactivated vaccines was evenly split between the thimero-
sal-free and thimerosal-containing formulations. Provid-
ers with more VFC-eligible children were more likely to
administer thimerosal-free vaccine, and those with fewer
VFC-eligible children were more likely to administer
thimerosal-containing inactivated vaccine (Table 1).
Pediatricians were queried to determine how burdensome
it would be to ask, in addition to other standard vaccina-
tion screening questions, whether the parent or healthcare
provider had ever noted asthma or wheezing in individualBMC Pediatrics 2009, 9:8 http://www.biomedcentral.com/1471-2431/9/8
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Table 1: Responses by Pediatricians Surveyed in Maryland to a Questionnaire Regarding Attitudes Regarding Influenza Immunization 
Practices
Demographics of respondents
Median age of practitioners, y (range) 48 (25–91)
Sex, %
Men 50.3
Women 49.7
Size and location of practice
Location, %
Suburban 54.1
Urban 37.2
Rural 6.0
Combination 2.7
Practice size, n
Median (range) 6000 (30–80,000)
Mean 8797
VFC-eligible children in practices, %
Median (range) 20 (0–100)
Mean 32
Influenza immunization practices
Patients in at-risk categories immunized with influenza vaccine, %
Children aged 6–23 mo 75
Children aged 24–59 mo 50
Children at high risk 80
Household contacts of at-risk individuals 45
When and where immunization occurs, %
Regular visits 98.8
Sick visits 74.6
Special infkuenza immunization clinics 72.2
Availability of callback system, % 39.8
Vaccine types used, %
Thimerosal-free inactivated, median (range) 50 (0–100)
Thimerosal-containing inactivated, median (range) 50 (0–100)
Live attenuated nasal spray, median (range) 5 (0–100)
How much more burdensome would it be to ask if the parent or a provider ever noted wheezing or asthma in 
the child (5-point scale; 1 = not at all and 5 = very), %
1 54.2
2 26.0
3 11.3
4 5.1
5 3.4
Profitability of influenza immunization
How profitable is influenza immunization of children?, %
Cost neutral 46.5
Produces a loss 14.5
Minimally profitable 36.6
What would improve profitability?, %
Better reimbursement 56.5
Better payment for vaccine administration 13.7
Less costly vaccine 8.7
All other responses 21.1
Participation in school-based immunization programs
Would you support a school-based immunization program?, % 85.7
Would you participate in a school immunization program?, % 60.8
What would persuade you to participate?, %
Financial remuneration 57.5
Civic involvement 53.1
Source of new patients 22.9
Nothing 22.3
How might you participate?, %
Off-site consultation 69.5
On-site supervision 52.5
Both on-site and off-site 38.4BMC Pediatrics 2009, 9:8 http://www.biomedcentral.com/1471-2431/9/8
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children, conditions which are potential warnings/pre-
cautions for the administration of the live attenuated
nasal spray influenza vaccine. Based on a 5-point scale
with 1 being "not at all" and 5 being "very," approxi-
mately 80% of those who replied noted that it would not
be a burden at all, or only a very slight burden, whereas
3.4% specified that it would be very burdensome to ask
this additional question (Table 1).
Profitability of immunization
Overall, pediatricians reported that influenza immuniza-
tion is not a profitable service. A total of 61% of respond-
ents reported that it either is cost neutral or produces a
loss; 36.6% noted it was minimally profitable. As noted
by two thirds of responses, the most significant barrier to
profits is poor reimbursement for costs of the vaccine and
administration. Acquisition price of the vaccines was not
seen as a major obstacle (Table 1).
Participation in school-based immunization programs
Eighty-six percent of respondents were receptive to sup-
porting school-based immunization programs, 61% indi-
cated that they would participate in such programs. Of
those who would participate, about 70% noted that they
would provide off-site consultation, half were receptive to
being available on-site in a supervisory role, and approxi-
mately one third would be willing to provide both on-site
and off-site services. Primary incentives for participation
were financial remuneration and civic involvement. Pro-
viders with high VFC-eligible populations were more
likely to state that they would participate in school-based
programs (76% of providers with ≥ 50% VFC-eligible
populations would participate compared with 53% of
those <50% VFC-eligible); however, providers with high
and low VFC-eligible populations expressed similar over-
all support of such programs (Table 1).
Discussion
Various provider groups have been surveyed regarding
their knowledge of recommendations for influenza
immunization [10-12]. Not surprisingly, pediatricians
tend to be the most knowledgeable with respect to current
recommendations for children, and this is the group that
was targeted in the present study.
Current recommendations state that influenza vaccina-
tion should be offered during routine healthcare visits,
sick visits, and influenza vaccine clinics, among other ven-
ues [4]. The survey results support that regular visits, sick
visits, and special clinics are regularly used by pediatri-
cians. Pediatricians noted that they administer an injecta-
ble form of influenza vaccine more frequently than the
nasal spray. In Maryland, the 2 largest medical insurers
did not reimburse for the nasal spray at the time of the
survey and this likely influenced vaccine choice. Despite
controversy over the safety of thimerosal-containing vac-
cines, preservative-containing and preservative-free inject-
able vaccines were equally used; VFC participation
appeared to increase utilization of thimerosal-free formu-
lations. Similar to previous reports [11], the majority of
practices did not have any callback system in place to
notify patients about immunization opportunities.
Respondents reported that they immunize children at
rates in excess of those reported by the CDC from national
surveys [13], likely due to overestimation of their actual
vaccination rates [11].
Overall, pediatricians do not believe the practice of
administering influenza vaccine to children is profitable
for their practice. Increased reimbursement for influenza
vaccine and its administration would likely increase vacci-
nation coverage in the future.
Almost 90% of respondents noted they would support
school-based immunization programs, the value of which
has been previously demonstrated [14-17]; approximately
60% stated they would participate in such programs.
Given the logistical obstacles to vaccinating large numbers
of school-aged children, school-based vaccination pro-
grams may be essential for achieving high rates of vaccina-
tion coverage in children 5 to 18 years of age, who are
recommended to be vaccinated beginning in the 2008–
2009 influenza season [4].
There are several inherent limitations to the survey find-
ings. Results of previous surveys of immunization prac-
tices among various physician groups indicate that
pediatricians are fairly diligent in providing feedback, and
response rates of 50% to 60% are common [10,11,18]. It
is unclear why the response rate was less than 25% in the
present study. There is potential for bias given this
response rate; responders may have disproportionate
interest in influenza vaccination. Because only pediatri-
cians in the state of Maryland were surveyed, extrapola-
tions to broader populations are problematic. In
particular, findings regarding school-based programs may
have been influenced by past school-based influenza vac-
cination programs conducted in Maryland [14,15,17].
Nevertheless, several of the findings pertaining to immu-
nization practices are consistent with survey results from
other investigators [11].
Conclusion
Vaccination was reported to occur at multiple types of
patient encounters, as recommended. Survey respondents
stated that practice-based immunization was not a profit-
able service. Pediatricians were supportive of school-
based immunization programs, and more than half stated
they would be actively involved in such programs. School-Publish with BioMed Central    and   every 
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based programs may be critical to achieving high vaccina-
tion coverage in the school-aged population.
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